-+ 0.00%
-+ 0.00%
-+ 0.00%

Lianhuan Pharmaceutical (600513.SH): Drugs such as bumetanil injections will be selected for centralized procurement of drugs nationwide

Zhitongcaijing·08/03/2026 08:41:02
Listen to the news

Zhitong Finance App News, Lianhuan Pharmaceutical (600513.SH) issued an announcement. The company and its holding subsidiary Xinxiang Changle Pharmaceutical Co., Ltd. participated in the 12th batch of centralized procurement tenders for national drugs organized and carried out by the State Organization Drug Joint Procurement Office. According to the “Announcement on the Results of the 12th Batch of Centralized Volume Procurement of Nationally Organized Drugs” issued by the Joint Procurement Office, the company and its holding subsidiary Changle Pharmaceutical: methasartan oral regular release dosage form, bumetanib injections, and vitamin B6 injections were selected for this centralized procurement.

This centralized drug procurement is the 12th batch of centralized procurement of national drugs organized by the Joint Procurement Office. In implementation, medical institutions are required to prioritize the use of selected varieties from centralized procurement and ensure that the agreed procurement volume is completed. After the company and its subsidiaries subsequently sign a procurement contract and implement it, it will help the above products to quickly open up the domestic sales market, increase market share, and enhance the company's brand influence.